Health In Tech (NASDAQ: HIT) announced that its executive management team, vice presidents across functions, and board of directors will voluntarily extend the lock‑up restrictions on all shares they hold for an additional six months beyond the original twelve‑month period set at the company’s IPO. The new lock‑up will keep these shares restricted until June 20 2026.
The company’s initial public offering on December 20 2024 raised $9.2 million, and the decision to extend the lock‑up reflects leadership’s confidence in the company’s growth trajectory. By keeping insiders from selling shares for an additional six months, the board signals a long‑term commitment to the AI‑backed eDIYBS platform and the expansion of its distribution network into mid‑ and large‑employer markets.
Financially, Health In Tech reported a 90% year‑over‑year increase in revenue for the third quarter of 2025, reaching $8.5 million, and earnings per share of $0.01. CEO Tim Johnson said, “Our leadership team remains highly committed to the long‑term growth of Health In Tech. By choosing to extend their lock‑up period, our executives are demonstrating confidence in the Company’s outlook and our ongoing initiatives in technology, underwriting automation, and market expansion.”
The lock‑up extension reduces near‑term selling pressure from insiders and supports the company’s strategy to invest in system enhancements, AI integration, and partnerships such as the collaboration with Verdegard Administrators. It also underscores the company’s focus on broadening its addressable market and strengthening its position in the insurtech space.
Overall, the move aligns with Health In Tech’s broader strategy to scale its eDIYBS platform, deepen its distribution network, and maintain a disciplined approach to capital allocation while signaling to investors that management believes the company’s long‑term prospects are strong.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.